Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31253 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.31519 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.28134 | 11 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.28219 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.29464 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.32825 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.73212 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.2972 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.29857 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.30441 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.29932 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30137 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.31159 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.30366 | 12 |